SCHEMBL3473620

SCHEMBL3473620

COc1cc2c(OC)c(-c3c(C)cc4c(C(=O)Nc5ccc(Oc6ccccc6)cc5)c(OC)c(OC)cc4c3OC)c(C)cc2c(C(=O)Nc2ccc(Oc3ccccc3)cc2)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.48
HTT P42858 2/20 0.47
GAA P10253 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 2/20 0.47
RAB9A P51151 1/20 0.47
PDGFRB P09619 3/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NR1H4 Q96RI1 1/20 0.44
MAPK1 P28482 1/20 0.43
GFER P55789 1/20 0.43
PDGFRA P16234 3/20 0.43
KIT P10721 2/20 0.43
FGFR1 P11362 1/20 0.43
FGFR2 P21802 1/20 0.43
FGFR4 P22455 1/20 0.43
FGFR3 P22607 1/20 0.43
FLT3 P36888 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3474066 0.91 KMT2A (0.52) HTTGAAMEN1KMT2AHPGD
SCHEMBL637059 0.77 SMN1; SMN2 (0.54) HTTMEN1KMT2ALMNARAB9A
SCHEMBL3472646 0.75 BCL2L1 (0.57) PGRNR1H4
SCHEMBL3471000 0.74 BCL2 (0.59) RAB9AALDH1A1MAPTPOLB
SCHEMBL3265536 0.74 BCL2 (0.59) RAB9AALDH1A1MAPTPOLB
SCHEMBL2757193 0.70 MEN1 (0.43) MEN1KMT2ALMNAHPGDGFER
SCHEMBL3473276 0.70 ADORA2A (0.49) LMNAHPGDSMN1; SMN2ALDH1A1MAPT
SCHEMBL29864839 0.70 TACR3 (0.65) GAAMEN1KMT2ALMNASMN1; SMN2
SCHEMBL28844477 0.70 TACR3 (0.65) GAAMEN1KMT2ALMNASMN1; SMN2
SCHEMBL3471960 0.69 BCL2 (0.55) MEN1KMT2ALMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418942-B1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS SANFORD-BURNHAM MEDICAL RES INST (US) 2017-08-23 EP disclosed
US-8436207-B2 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2013-05-07 US disclosed
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267781-A1 NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS HAX1, BAX, APOL1 PGR 2529/4885HTT 1095/4885GAA 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.